PFBT
VERA icon

Parkside Financial Bank & Trust’s Vera Therapeutics VERA Stock Holding History

Parkside Financial Bank & Trust’s Portfolio VERA Stock Details VERA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.61K Buy
40
+2
+5% +$86 ﹤0.01% 2199
2025
Q4 		$1.93K Buy
38
+13
+52% +$462 ﹤0.01% 2110
2025
Q3 		$727 Buy
25
+5
+25% +$116 ﹤0.01% 2401
2025
Q2 		$472 Hold
20
– – ﹤0.01% 2583
2025
Q1 		$481 Buy
+20
New +$643 ﹤0.01% 2424

Other funds holding VERA

ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $2.63B AUM 117.41% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Parkside Financial Bank & Trust's VERA Position: Q1 2026 in Review

Parkside Financial Bank & Trust increased its Vera Therapeutics (VERA) stake by 5.3% in Q1 2026, buying an estimated $86 and bringing the position to 40 shares worth $1.61K. The position accounts for ﹤0.01% of the portfolio, ranked #2199.

Parkside Financial Bank & Trust first reported a position in VERA in Q1 2025 and has held it in 5 quarters since. The position peaked at $1.93K in Q4 2025. 229 funds tracked by Wall St. Rank hold VERA as of Q1 2026.

  • Parkside Financial Bank & Trust held 40 shares of Vera Therapeutics worth $1.61K as of Q1 2026.
  • Parkside Financial Bank & Trust bought 2 Vera Therapeutics shares in Q1 2026, an estimated $86.
  • Vera Therapeutics made up ﹤0.01% of Parkside Financial Bank & Trust's portfolio in Q1 2026, its #2199 holding.
  • Parkside Financial Bank & Trust first reported a position in Vera Therapeutics in Q1 2025 and has held it in 5 quarters since.
  • Parkside Financial Bank & Trust's Vera Therapeutics position peaked at $1.93K in Q4 2025.
  • 229 funds tracked by Wall St. Rank held Vera Therapeutics as of Q1 2026.

Based on Parkside Financial Bank & Trust's 13F filing for Q1 2026, filed 13 May 2026.